Annual report pursuant to Section 13 and 15(d)

Segment Disclosures

v3.6.0.2
Segment Disclosures
 12 Months Ended
Dec. 31, 2016
Segment Reporting [Abstract]  
Segment Disclosures
17. Segment Disclosures
 
During the third quarter of 2016, the Company determined industrial sales to be a reportable segment as a result of progress in commercialization and sales of its industrial devices. We have recast certain prior period amounts to conform to the way we internally manage and monitor segment performance.
 
The Company has three reportable segments, Medical Devices, Industrial Sales, and Engineering Services. The Medical Devices segment designs and engineers technology, and commercializes, manufactures, and sells exoskeletons for applications in the medical markets. The Industrial Sales segment designs, engineers, commercializes, and sells exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. Engineering Services generates revenue principally from collaborative research and development service arrangements, technology license agreements, and government grants where the Company uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities such as the National Science Foundation and the Defense Advanced Research Projects Agency.
 
The Company evaluates performance and allocates resources based on segment gross profit margin. The reportable segments are each managed separately because they serve distinct markets, and one segment provides a service and the others manufacture and distribute unique products. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.
 
Segment reporting information is as follows:
 
 
 
Medical
 
 
Industrial
 
 
Engineering
 
 
 
 
 
 
Devices
 
 
Sales
 
 
Services
 
 
Total
 
Year ended December 31, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
$
12,081
 
 
$
1,253
 
 
$
887
 
 
$
14,221
 
Cost of revenue
 
 
9,767
 
 
 
948
 
 
 
559
 
 
 
11,274
 
Gross profit
 
$
2,314
 
 
$
305
 
 
$
328
 
 
$
2,947
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Year ended December 31, 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
$
4,252
 
 
$
-
 
 
$
4,409
 
 
$
8,661
 
Cost of revenue
 
 
3,926
 
 
 
-
 
 
 
3,556
 
 
 
7,482
 
Gross profit
 
$
326
 
 
$
-
 
 
$
853
 
 
$
1,179
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Year ended December 31, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
$
2,924
 
 
$
-
 
 
$
2,403
 
 
$
5,327
 
Cost of revenue
 
 
2,048
 
 
 
-
 
 
 
1,720
 
 
 
3,768
 
Gross profit
 
$
876
 
 
$
-
 
 
$
683
 
 
$
1,559
 
 
Geographic revenue information based on location of customer is as follows:
 
 
 
Years Ended December 31
 
 
 
2016
 
 
2015
 
 
2014
 
United States
 
$
9,042
 
 
$
6,382
 
 
$
3,873
 
All Other
 
 
5,179
 
 
 
2,279
 
 
 
1,454
 
 
 
$
14,221
 
 
$
8,661
 
 
$
5,327